Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reissue Patent
1997-04-02
2002-05-28
Meeks, Timothy (Department: 1762)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C427S002260, C427S002270, C427S523000, C427S527000, C427S529000, C623S023560
Reissue Patent
active
RE037718
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to bioactive ceramics and to methods of treating bioactive ceramics to increase their bioactivity and improve their biointegration. In a preferred embodiment, an ion beam is used to treat orthopaedic, dental, or soft tissue implants made of ceramic oxides, particularly components made of bioactive ceramics, to accelerate implant-tissue bonding in vivo.
BACKGROUND
Bioactive materials are defined as materials which form a chemical bond with living tissue. Ceramic implant materials, such as alumina and calcium phosphate-based ceramics, may be bio-inert, biodegradable, resorbable, or bioactive depending upon their composition. True bonding between bone and man-made materials has been observed only within a limited group of ceramics, such as, the BIOGLASS® family, CERA-VITAL™, and apatite-wollastonite, all of which are based on ceramic oxide formulations.
Bioactive ceramic materials are believed to bond to bone because an oxide, or a ratio of oxides, present in the ceramic material permits a time-dependent, kinetic modification of the surface of the ceramic through an ion-exchange reaction that is triggered upon implantation into body fluids near bone or soft tissue. Upon implantation, a biologically-active calcium hydrocarbonate apatite (HA) layer forms at the surface of the ceramic. This HA layer is chemically and crystallographically equivalent to the mineral phase in bone. The equivalence between the ceramic HA layer and bone is considered to be responsible for the interfacial bonding between the ceramic implant and the bone or soft tissue. Specific to the bioactive glass-ceramic materials, the rate of release of calcium from apatite-wollastonite normally is constrained by the need to balance out-diffusion of cations and either phosphate or silicate ions in order to maintain charge neutrality.
Two problems currently exist which prevent widespread use of bioactive materials for implantation into soft or hard tissue, and for load bearing applications. These problems are (1) the extended time period required for significant hard or soft tissue-ceramic bonding following implantation, and (2) the ultimate bond strength achieved. These problems are present regardless of whether the material used for the implant is an amorphous bioactive material, such as the BIOGLASS® family, or a crystalline or semi-crystalline material, such as CERA-VITAL™ or apatite-wollastonite. However, the problems are especially critical when the material is a bioactive glass-ceramic material having a primarily crystalline structure. The glass-ceramics are stronger and better suited for load-bearing applications, but are significantly less bioactive than their glassy counterparts.
The kinetics of the ion-exchange reaction—that is, the release of critical ions (Ca, Si, Mg, Na, P, etc.) required to form a biologically-active HA layer—are believed to relate directly to both the rate of hard or soft tissue-ceramic bonding and to the strength of the resulting bond. Because phosphate ions present in body fluids can react with calcium to form HA, it is believed that the critical requirement for bonding and osseointegration of ceramics is the release of calcium.
In general, crystalline materials have stronger atomic bonds and increased stability as opposed to amorphous materials. As a result, the rate of the ion-exchange reaction for crystalline or semi-crystalline materials is significantly slower than for more amorphous materials under the same conditions. This significantly slower ion exchange reaction causes glass-ceramics to have a lower bioactivity than amorphous materials.
The rate of bonding between tissue and both crystalline and amorphous ceramics could be increased if a method could be found to increase the kinetics of this ion-exchange reaction. This would allow BIOGLASS® and the stronger bioactive glass-ceramics to become more bioactive, rendering the bioactive glass-ceramics suitable for appropriate load-bearing applications. An increase in the rate of these critical ion-exchange reactions also should result in a decreased period of patient convalescence, leading to a greater implant success rate, and an increased lifetime for ceramic implants.
SUMMARY OF THE INVENTION
The present invention provides for faster and stronger tissue-implant bonding by treating a ceramic implant with an ion beam to modify the surface of the ceramic. The surface modification can give the ceramic improved ion-exchange properties depending upon the particular ceramic and the type of ions used. In a preferred embodiment, a bioactive ceramic orthopaedic, dental, or soft tissue implant is bombarded with a beam of cations. When implanted in the body, the surface modification causes an increase in the release of critical ions, such as calcium or phosphorus, from the surface of the ceramic implant, and thereby accelerates implant-tissue bond formation. The mechanism and rate of the ion-exchange reaction, and the type and quantity of ions released by the ceramic, can be controlled by: (a) varying the depth to which the ions penetrate by varying the energy of ion bombardment or the angle of the ceramic surface related to the ion beam; (b) varying the dose (or ions per unit area) of the ion beam; and (c) varying the type and combination of ions used.
REFERENCES:
patent: 4656083 (1987-04-01), Hoffman et al.
patent: 4702930 (1987-10-01), Heide et al.
patent: 4894255 (1990-01-01), Page et al.
patent: 4944754 (1990-07-01), Linkow et al.
patent: 5242706 (1993-09-01), Cotell et al.
patent: 5380547 (1995-01-01), Higgins
patent: 5383934 (1995-01-01), Armini et al.
patent: 9307924 (1993-04-01), None
T. Fujiu, et al.Difference of bond bonding behavior among surface active glasses and sintered apatite,Journal of Biomedical Materials Research, vol. 18, 845-859, 1984.
L.L. Hench, et al.,Reaction Kinetics of Bioactive Ceramics Part IV: Effect of Glass and Solution Composition,Bioceramics 5, 67-74, 1992.
L.L. Hench,Surface Reaction Kinetics and Adsorption of Biologicial Moieties: A Mechanistic Approach to Tissue. Attachment,Univ. Of Toronto Press, 33-44.
T. Kokubo et al.,Chemical reaction of bioactive glass and glass-ceramics with a simulated body fluied,Journal of Material Science: Materials in medicine 3, 79-83, 1992.
Tadashi Kokubo,Surface Chemistry of Bioactive Blass-Ceramics,Journal of Non-Crystalline Solids 120, 138-151, 1990.
M. Regina, et al.,Solution effects on the surface reactions of three bioactive glass compositions,Journal of Biomedical Materials Research 27, 1485-1493, 1993.
Takashi Nakamura, et al.,A new glass-ceramic for bone replacement: Evaluation of its bonding to bone tissue,Journal of Biomaterials Research, vol. 19, 685-698, 1985.
G.H. Takaoka et al., Surface Modification of Bioactive Ceramic (Artificial Bone) by Ion implantation Materials Res. Soc. Symp., Prac. vol. 252, pp. 23-28, 1992.
June Wilson, et al.Toxicology and biocompatibility of bioglasses,Journal of Biomedical Materials Reasearch, vol. 15, 805-817, 1981.
Larry L. Hench,The Kinetics of Bioactive Ceramics, Bioceramics,vol. 31, 43-53.
Larry L. Hench,Bioceramics: From Concept to Clinic,J. Am. Ceram. Soc., vol. 74, 1487-15120, 1991.
Tadashi Kikubo,Bioactive Glass Ceramics: Properties and Applications,Biomaterials, vol. 12, 155-163, 1991.
Ong, et al., Structure, solubility and bond strength of thin calcium phosphate coatings produced by ion beam sputter deposition, 6055 Biomaterials 13 (1992) No. 4, Guildford, Surrey, GB.
Blanchard Cheryl
Dearnaley Geoffrey
Lankford, Jr. James
Meeks Timothy
Paula D. Morris & Associates P.C.
Southwest Research Institute
LandOfFree
Ion beam modification of bioactive ceramics to accelerate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ion beam modification of bioactive ceramics to accelerate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ion beam modification of bioactive ceramics to accelerate... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2892672